Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes  by Castell, José V. et al.
Volume 232, number 2, 347-350 FEB 05879 May 1988 
Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the 
synthesis of acute phase proteins in human hepatocytes 
Jose V. Castell, Maria J. Gomez-Lechbn*, Martina David, To&o Hirano+, 
Tadamitsu Kishimoto+ and Peter C. Heinrich 
Biochemisches Institut. Universitiit Freiburg, Hermann-Herder-Str. 7, D-7800 Freiburg, FRG, Tentro de Investigation, 
Hospital La Fe, INSALUD, Avda de Campanar, 21, E-46009 Vale&a, Spain and ‘Institute for Molecular and Cellular 
Biology, Division of Immunology, Osaka University, 1-3, Yamada-oka, Suita, Osaka 565, Japan 
Received 25 March 1988 
Recombinant human IL-6 (rhIL-6) is a potent inducer of the synthesis of acute phase proteins in adult human hepato- 
cytes. A wide spectrum of acute phase proteins is regulated by this mediator. After labeling of rhIL-6 stimulated human 
hepatocytes with P”S]methionine acute phase protein synthesis was measured by immunoprecipitation. Serum amyloid 
A, C-reactive protein, haptoglobin, ai-antichymotrypsin and fibrinogen were strongly induced (26-, 23-, 8.6-, 4.6 and 
3%fold increases, respectively). Moderate increases were found for q-antitrypsin (2.7-fold) and q-acid glycoprotein (2.7- 
fold). RhIL-6 had no effect on o;-macroglobulin, whereas fibronectin, albumin and transferrin decreased to 64, 56 and 
55% of controls. In the cases of serum amyloid A, haptoglobin, q-antichymotrypsin, a,-antitrypsin and q-acid glyco- 
protein, dexamethasone enhanced the action of rhIL-6. We conclude that rhIL-6 controls the acute phase response in 
human liver cells. 
Acute-phase protein; Interleukin-6; Hepatocyte stimulating factor; B-cell stimulatory factor 2; (Human hepatocyte) 
1. INTRODUCTION 
The course of an inflammatory response occur- 
ring in a variety of pathological conditions is 
characterized by changes in serum levels of a group 
of proteins, the acute phase proteins [1,2]. In man 
C-reactive protein, serum amyloid A, fibrinogen, 
haptoglobin, al-antitrypsin, al-acid glycoprotein 
are positive acute phase reactants, while 
az-macroglobulin remains essentially unchanged. 
Serum transferrin and albumin decrease during the 
acute phase response [l-3]. It is presently believed 
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that the major site of synthesis for the acute phase 
proteins are the parenchymal cells of the liver. 
In rat hepatocyte primary cultures and in 
various cell lines it has been shown that the acute 
phase protein expression can be induced by 
mediators synthesized and secreted by mononu- 
clear phagocytes [4- 131. Recent work strongly sug- 
gests that interleukin-6 also known as B-cell 
stimulatory factor-2, hybridoma plasmacytoma 
growth factor, 26 kDa protein or interferon-@ 
[14] functions as an important mediator in the 
acute phase response in rat and human hepatoma 
cells [15-171. RhIL-6 also stimulated acute phase 
protein synthesis in the rat in vivo [18]. 
Thus far, however, there is no direct evidence 
for IL-6 as an acute phase mediator in human 
hepatocytes. Here we show for the first time that 
rhIL-6 is a potent regulator of acute phase protein 
synthesis in adult human liver cells. 
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2. MATERIALS AND METHODS 
2.1. Chemicals 
L-[“SlMethionine (1000 Ci/mmol) was purchased from the 
Radiochemical Centre (Amersham, England). Collagenase 
(>300 units/mg) was from Boehringer (Mannheim, FRG). Pro- 
tein A-Sepharose CL-4B was obtained from Pharmacia 
(Freiburg, FRG). Antibodies to human plasma proteins were 
from Dakopatts (Hamburg, FRG), recombinant human 
BSF-2/IL-6 (5 x lo6 units/mg protein) was produced in E. coli 
as a fusion protein, processed and purified as described in [ 191. 
2.2. Preparation of human hepatocyte primary cultures 
Human hepatocytes were obtained after perfusion with col- 
lagenase of a small surgical biopsy (1.5 g) of a healthy in- 
dividual. Cell viability was >95%. Hepatocytes (1.5 x lo5 
cells/well) were seeded on 24-well dishes (Falcon, no.3047) 
previously coated with fibronectin (1.5 fig/cm’) and cultured in 
Ham’s F-12 medium supplemented with 0.2% bovine serum 
albumin, low8 M insulin and 2% newborn calf serum. 1 h later 
90% of the cells were attached and medium was changed. After 
24 h cells were shifted to Ham’s F-12 medium containing 0.2% 
bovine serum albumin, 10-s M insulin and lo-* M dex- 
amethasone. 
2.3. Synthesis of acute phase proteins 
After 48 h in culture hepatocytes were stimulated with 100 
units/ml of rhIL-6 with or without lo-’ M dexamethasone for 
20 h. Medium was changed and hepatocytes were labeled for 
4 h with 25 &i of [35S]methionine per ml methionine-free 
culture medium. The various acute phase proteins were im- 
munoprecipitated from 0.35 ml of the hepatocyte culture 
medium, subjected to SDS-polyacrylamide gel electrophoresis 
and fluorography as described in previous publications [20,21]. 
3. RESULTS 
The aim of the present study was to investigate, 
whether rhIL-6 was capable of inducing acute 
phase protein synthesis in human hepatocyte 
primary cultures. Adult human hepatocytes were 
incubated with 100 units per ml rhIL-6 for 20 h 
with or without supplementation of lo-’ M dex- 
amethasone. This rhIL-6 concentration as well as 
the time for stimulation was chosen in analogy to 
experiments, which we had carried out with the 
human hepatoma cell lines HepG2 and Hep3B2. 
After labeling hepatocytes with [“Slmethionine 
for 3 h, 12 plasma proteins were immunoprecipi- 
tated from the media and analyzed by SDS-poly- 
Fig. 1. Induction of acute phase protein synthesis in human hepatocyte primary cultures. Adult human hepatocytes cultured as detailed 
in section 2 were incubated with 100 U/ml of rhIL-6 (lane 2), lo-’ M dexamethasone (lane 3), and 100 U/ml of rhIL-6 plus low7 M 
dexamethasone (lane 4) for 20 h. Non-treated hepatocytes were used as a control (lane 1). Culture medium was replaced by methionine- 
free RPM1 1640 medium containing 25 ,Ki L-[3sS]methionine per ml. After a labeling period of 4 h the acute phase proteins indicated 
in the figure were immunoprecipitated with specific antibodies and analyzed by SDS-polyacrylamide gel electrophoresis and 
autoradiography. SAA, serum amyloid A; CRP, C-reactive protein; HTG, haptoglobin; ACH, cri-antichymotrypsin; FBN, fibrinogen; 
AAT, cYi-antitrypsin; AGP, crt-acid glycoprotein; AMG, cu2-macroglobulin; FNT, fibronectin; TRF, transferrin; ALB, albumin. 
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acrylamide gel electrophoresis and subsequent 
fluorography. Essentially for all acute phase pro- 
teins the immunoprecipitations led to single radio- 
actively labeled bands. In the cases of fibrinogen 
and fibronectin the antisera had been raised 
against the holoproteins. Since fibrinogen is com- 
posed of 6 (@z~z) subunits and fibronectin of 2 
different subunits, the expected polypeptides were 
detected. It can be seen in fig.1 that the response 
to rhIL-6 is quite different for the various proteins 
studied. Serum amyloid A and C-reactive protein 
are very strongly induced, and a strong stimulation 
was also found for haptoglobin, cur-antichy- 
motrypsin and fibrinogen. Only moderate in- 
creases were observed for cur-antitrypsin and 
al-acid glycoprotein. cyz-Macroglobulin, which is 
no acute phase protein in humans, did not change. 
In the cases of fibronectin, transferrin and al- 
bumin decreases were observed. No newly synthe- 
sized serum amyloid P could be detected under our 
experimental conditions. 
In order to quantify the effects of rhIL-6 on the 
synthesis of the different acute phase proteins seen 
in fig.1, the individual protein bands were excised 
from the gel and their radioactivities were deter- 
mined (table 1). RhIL-6 alone stimulated the syn- 
thesis and secretion of secretory proteins l.bfold, 
whereas rhIL-6 in combination with lo-’ M dex- 
amethasone led to a 1.7-fold increase. In contrast, 
rhIL-6 had no effect on cellular protein synthesis. 
From the analysis of the data of the various 
acute phase proteins listed in table 1, a subdivision 
into four groups is possible. Two proteins, serum 
amyloid A and C-reactive protein are very strongly 
induced in human hepatocytes (>20-fold). Hap- 
toglobin, act-antichymotrypsin and fibrinogen fall 
into a second group characterized by changes be- 
tween 3- and IO-fold. The third group comprises 
protein exhibiting changes between l- and 3-fold 
namely qr-antitrypsin, al-acid glycoprotein and 
az-macroglobulin. Finally, the negative acute 
phase proteins fibronectin, transferrin and 
albumin form a fourth group. 
It is interesting that all the acute phase proteins 
studied could be induced by rhIL-6 alone. In the 
cases of serum amyloid A, haptoglobin, 
cur-antichymotrypsin, cur-antitrypsin and &r-acid 
glycoprotein, dexamethasone further increased the 
effect of rhIL-6. 
Table 1 
Synthesis of acute phase proteins by rhIL-6 stimulated human 
hepatocytes in culture 
Proteins Radioactivity 
(cpm//g cellular protein) 
Control RhIL-6 Dex RhIL-6 + 
Dex 
Total protein 
(cells) 
Total protein 
(medium) 
4810 3780 5460 4650 
0.9 1.3 1.1 
309 441 408 525 
1.4 I.3 1.7 
(cpm/mg cellular protein) 
Serum amyloid A 
C-reactive protein 
105 
90 
Haptoglobin 
cur-Antichymo- 
trypsin 
Fibrinogen 
700 
7695 
1010 
cur-Antitrypsin 
cur-Acid glyco- 
protein 
cyz-Macroglobulin 
12290 
585 
245 
Fibronectin 690 
Transferrin 625 
Albumin 8970 
490 465 2840 
4.9 4.6 26 
1998 155 2030 
22. I 1.7 22.5 
2545 1410 6610 
1.3 1.8 8.6 
15910 16695 35 170 
2.0 2.1 4.6 
3775 980 3875 
3.7 1.0 3.8 
22885 20245 33020 
1.9 1.6 2.7 
975 1120 1580 
1.6 1.9 2.7 
225 225 240 
1.0 1.0 1.0 
335 710 445 
0.48 1.0 0.64 
180 760 340 
0.3 1.2 0.55 
4280 13485 5150 
0.47 I.5 0.56 
Radioactivity of total cellular and medium protein after 
trichloroacetic acid precipitation is expressed as cpm/pg cellular 
protein. The immunoprecipitated acute phase proteins were 
separated by SDS-polyacrylamide gel electrophoresis as 
described in the legend of fig.1 and their radioactivity was 
expressed as cpm/mg cellular protein. Each number represents 
the average of 6 independently treated culture plates of human 
hepatocytes. Values in italics represent relative increases over 
their respective controls 
4. DISCUSSION 
Most studies on human acute phase protein in- 
duction have been carried out with the well dif- 
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ferentiated human hepatoma cell lines HepG2 and 
Hep3B2 [12,13]. Upon stimulation these cells ex- 
press only some acute phase proteins, such as 
fibrinogen, haptoglobin, c~i-antichymotrypsin, 
albumin (Caste11 et al., unpublished). However, 
they do not synthesize the major human acute 
phase proteins, C-reactive protein and serum 
amyloid A [12,22]. The experiments presented in 
this paper clearly show that rhIL-6 induces in 
cultured human hepatocytes essentially the same 
spectrum of acute phase proteins, in particular C- 
reactive protein and serum amyloid A, as that 
found in man during inflammatory states [l-3]. 
Whereas IL-6 has recently been shown to be the 
most important acute phase protein inducer in the 
rat in vivo [18], no such direct evidence exists for 
man. Only indirect evidence, namely a correlation 
between serum levels of IL-6 and the acute phase 
C-reactive protein has been reported thus far [23]. 
Our results obtained with cultured human 
hepatocytes trongly suggest IL-6 to be the major 
inflammatory mediator in humans. 
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